ATE494555T1 - Verfahren in verbindung mit einer hepatitis-b- infektion - Google Patents

Verfahren in verbindung mit einer hepatitis-b- infektion

Info

Publication number
ATE494555T1
ATE494555T1 AT04818749T AT04818749T ATE494555T1 AT E494555 T1 ATE494555 T1 AT E494555T1 AT 04818749 T AT04818749 T AT 04818749T AT 04818749 T AT04818749 T AT 04818749T AT E494555 T1 ATE494555 T1 AT E494555T1
Authority
AT
Austria
Prior art keywords
hepatitis
infection
procedure related
individual
pres1
Prior art date
Application number
AT04818749T
Other languages
English (en)
Inventor
Ulla Hellstrom
Staffan Sylvan
Original Assignee
Hbv Theranostica Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hbv Theranostica Ab filed Critical Hbv Theranostica Ab
Priority claimed from PCT/EP2004/011958 external-priority patent/WO2005050214A2/en
Application granted granted Critical
Publication of ATE494555T1 publication Critical patent/ATE494555T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT04818749T 2003-11-12 2004-10-22 Verfahren in verbindung mit einer hepatitis-b- infektion ATE494555T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51915203P 2003-11-12 2003-11-12
GBGB0326416.5A GB0326416D0 (en) 2003-11-12 2003-11-12 Methods and means relating to hepatitis B infection
PCT/EP2004/011958 WO2005050214A2 (en) 2003-11-12 2004-10-22 Methods and means relating to hepatitis b infection

Publications (1)

Publication Number Publication Date
ATE494555T1 true ATE494555T1 (de) 2011-01-15

Family

ID=29726432

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04818749T ATE494555T1 (de) 2003-11-12 2004-10-22 Verfahren in verbindung mit einer hepatitis-b- infektion

Country Status (5)

Country Link
US (1) US8076085B2 (de)
CN (1) CN1906488A (de)
AT (1) ATE494555T1 (de)
DE (1) DE602004030936D1 (de)
GB (1) GB0326416D0 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100949310B1 (ko) * 2007-11-21 2010-03-23 한국과학기술연구원 세포 영상 기법을 이용한 ｈｂｖ 캡시드 단백질과 표면단백질 간 상호작용 측정 방법과 이를 이용한 ｈｂｖ 증식억제물질의 검색방법
EP2629096A1 (de) * 2012-02-20 2013-08-21 Roche Diagniostics GmbH HBV-Immunkomplexe zur Reaktionsvorhersage und Therapieüberwachung bei chronischen HBV-Patienten

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847080A (en) * 1984-03-07 1989-07-11 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipide vesicle carriers
US5204096A (en) 1984-03-07 1993-04-20 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
JPH01500515A (ja) 1986-06-20 1989-02-23 スクリップス　クリニック　アンド　リサーチ　ファウンデーション Ｂ型肝炎ウィルス表面抗原のプレｓ領域のｔ及びｂ細胞エピトープ
EP0491077A1 (de) 1990-12-19 1992-06-24 Medeva Holdings B.V. Zusammensetzung verwendbar als therapeutisches Mittel gegen chronische virale Leberkrankheiten
WO1994004922A1 (en) 1992-08-21 1994-03-03 Abbott Laboratories Methods for monitoring effectiveness of interferon therapy in individuals with hcv infections

Also Published As

Publication number Publication date
US8076085B2 (en) 2011-12-13
CN1906488A (zh) 2007-01-31
DE602004030936D1 (de) 2011-02-17
US20070054264A1 (en) 2007-03-08
GB0326416D0 (en) 2003-12-17

Similar Documents

Publication Publication Date Title
HK1081207A1 (en) Hbv precore protein capable of forming particles
DK1294893T3 (da) Modifikation af hepatitis B-kerneantigen
EP1018344A3 (de) HLA-reduzierte CTL-Epitope gegen Hepatite B-Virus
CY1108789T1 (el) Καθαρισμος αντιγονων hbv για χρηση σε εμβολια
EP2099825A4 (de) Rekombinante antikörper gegen den hepatitis c-virus und verfahren zu deren erhalt und verwendung davon
DE602004026891D1 (de) Tlr7-liganden zur behandlung von hepatitis c
ZA202104213B (en) Antibodies that neutralize hepatitis b virus and uses thereof
DK0726758T3 (da) Peptider til inducering af cytotoksiske T-lymfocytreaktioner over for hepaptitis B virus
SG10201806025TA (en) Neutralizing human monoclonal antibodies against hepatitis b virus surface antigen
EP1752768A4 (de) Verfahren zum nachweis von hepatitis-b-virus
PT1766098E (pt) Anticorpos monoclonais de coelho para antigénios de superfície da hepatite b e métodos para utilizar os mesmos
DE60123042D1 (de) L-fmau zur behandlung von hepatitis-delta-virus-infizierung
ATE494555T1 (de) Verfahren in verbindung mit einer hepatitis-b- infektion
DK88988A (da) T- og b-celleepitoper af pre-s-regionen af hepatitis-b-virus-overfladeantigen
EP0389983A3 (de) Monoklonale Antikörper gegen PreS2- und PreS1-Polypeptide des Umhüllungsproteins des Hepatite B-Virus
WO2005050214A3 (en) Methods and means relating to hepatitis b infection
MX2022002231A (es) Composiciones de anticuerpos y metodos para tratar la infeccion por el virus de la hepatitis b.
ATE552264T1 (de) Neue oberflächenprotein- (hbsag-) variante des hepatitis b virus
IL161138A0 (en) Treatment of hepatitis b virus infection with human monoclonal antibodies
WO2003040341A3 (en) Anti-hepatitis a virus antibodies
DE602006004074D1 (de) Verfahren zur formung eines entfernbaren randerweiterungselements
EP1322761A4 (de) HUMANISIERTER ANTIKöRPER GEGEN DAS OBERFLäCHENANTIGEN S DES HEPATITIS B VIRUS UND HERSTELLUNGSVERFAHREN
Seto et al. Future prevention and treatment of chronic hepatitis B infection
WO2004037202A3 (en) Gb virus c and methods of treating viral infections
WO2020254878A8 (en) Improved therapeutic composition comprising hepatitis b antigen having s, pre-s1 and pre-s2 protein, aluminium phosphate and interferon-alpha and use thereof for treatment of hepatitis b.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties